BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 3 filers reported holding BEAM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $378,603 | +1.1% | 13,909 | -10.7% | 0.27% | -5.2% |
| Q3 2023 | $374,555 | -6.1% | 15,574 | +24.7% | 0.29% | +9.9% |
| Q2 2023 | $398,838 | +26.9% | 12,491 | +21.7% | 0.26% | +19.1% |
| Q1 2023 | $314,222 | -21.8% | 10,262 | -0.3% | 0.22% | -34.1% |
| Q4 2022 | $402,000 | -14.1% | 10,290 | +4.8% | 0.33% | -15.7% |
| Q3 2022 | $468,000 | +23.8% | 9,823 | +0.6% | 0.40% | +355.2% |
| Q2 2022 | $378,000 | – | 9,769 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |